- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03961386
FallsTalk Falls Prevention Program for Caregivers and Persons With Memory Loss or Dementia (FT-C)
June 4, 2019 updated by: Brookside Research & Development Company
Development of a Prototype FallsTalk Caregiver Resource System
This randomized-control trial involves dyads consisting of a family caregiver (CG) and a person with memory loss or dementia (PwD).
The FallsTalk Caregiver Resource System (FT-C) intervention is administered by the CG, whose role is to modify their interactions with the PwD.
FT-C will create a 3-way partnership between an Interventionist and the dyad, capitalizing on CG-PwD interactions.
The PwD will be observed by the CG and both will be evaluated by the study team.
Brief daily FT-C intervention by the CG will stimulate the PwD's awareness and individualized weekly CG- check-ins with the Interventionist will increase the CG's skills.
Our hypothesis is that FT-C will increase PwD's awareness of personal fall threats and encourage new falls prevention behaviors, resulting in reduced fall rates.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This is a single-site preliminary trial enrolling dyads in Western Washington state only.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Freeland, Washington, United States, 98249
- Recruiting
- Brookside Research & Development
-
Contact:
- Victoria Panzer, PhD
- Phone Number: 206-317-3173
- Email: VPBrookside@fallscape.org
-
Contact:
- Kristin Koontz, RN
- Phone Number: 206-317-3173
- Email: Info@fallscape.org
-
Principal Investigator:
- Victoria Panzer, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Caregiver (CG) Inclusion Criteria:
- residence in western Washington state
- minimum age= 18
- family CG
- primary CG
- some daily personal contact with Person with Dementia (PwD) for 1 month
- basic computer skills and telephone access
- able to commit to 6 month study.
Persons with Dementia (PwD) Inclusion Criteria:
- living at home with residence in western Washington state
- minimum age= 55
- at least one fall in last 6 months or regular loss of balance
- can ambulate at least 6 feet
- ability to communicate thoughts
- willingness to participate.
CG Exclusion Criteria:
- Professional CG (unless primary CG for family member)
- distance CG unable to be physically present with PwD daily for 1 month
- terminal illness with less than 6 months to live
- CG has significant memory loss.
PwD Exclusion Criteria:
- Residence outside of western Washington state
- Living in Residential care setting
- non-communicative
- terminal illness with less than 6 months to live
- wheel chair or bed bound.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: FallsTalk-C
FallsTalk CG intervention
|
The FT-C experimental intervention involves two face-to-face visits including Initial and Follow-up Interviews, CG training, daily interaction with the PwD using a computer with FT-C software, weekly check-in calls, weekly postcard completion and monthly check-in calls for at least six months and up to one year.
The FallsTalk intervention involves two face-to-face visits including Initial and Follow-up Interviews,CG training, daily interaction with the PwD, weekly check-in calls, weekly postcard completion and monthly check-in calls for at least six months and up to one year.
Other Names:
|
|
Active Comparator: FallsTalk
FallsTalk intervention
|
The FallsTalk intervention involves two face-to-face visits including Initial and Follow-up Interviews,CG training, daily interaction with the PwD, weekly check-in calls, weekly postcard completion and monthly check-in calls for at least six months and up to one year.
Other Names:
|
|
No Intervention: PostCardOnly
Postcard only- Control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of falls
Time Frame: weekly for up to one year
|
number of falls per month
|
weekly for up to one year
|
|
Change of Residence
Time Frame: weekly for up to one year
|
Report of change of primary residence
|
weekly for up to one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fall Threat Awareness
Time Frame: Pre-test- 5 clips at Initial interview; Post-test- 5 clips at Follow-up interview one month later
|
Ability to identify potential fall risks in 10 standardized novel multimedia clips administered in random order
|
Pre-test- 5 clips at Initial interview; Post-test- 5 clips at Follow-up interview one month later
|
|
Activity-Specific Balance Confidence scale
Time Frame: Pre-test at Initial interview; Post-test at Follow-up interview one month later
|
The Activity-Specific Balance Confidence scale is a standardized 16 item scale that measures an individual's self-efficacy about preventing a fall or loss of balance.
The maximum score is 1600.
Each item is scored from 0-100 with 0 indicating no confidence and 100 meaning complete confidence.
|
Pre-test at Initial interview; Post-test at Follow-up interview one month later
|
|
Caregiver Falls Prevention Concerns
Time Frame: Survey administered at study entry and Follow-up visit.
|
Specific concerns identified by Caregiver with respect to preventing falls in the person they care for.
|
Survey administered at study entry and Follow-up visit.
|
|
Burden Scale for Family Caregivers
Time Frame: BSFC is administered at Initial interview and Follow-up interview one month later.
|
The Burden Scale for Family Caregivers is a standardized 28 item scale that assesses subjective burden of the CG.
The items are scored as strongly agree, agree, disagree or strongly disagree and the maximum score is 84.
A score of 0 indicates no burden and a score of 84 indicates a very severe burden with a high risk of psychosomatic symptoms.
|
BSFC is administered at Initial interview and Follow-up interview one month later.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Victoria Panzer, PhD, Brookside Research & Development
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 13, 2019
Primary Completion (Anticipated)
December 1, 2019
Study Completion (Anticipated)
May 1, 2020
Study Registration Dates
First Submitted
May 22, 2019
First Submitted That Met QC Criteria
May 22, 2019
First Posted (Actual)
May 23, 2019
Study Record Updates
Last Update Posted (Actual)
June 6, 2019
Last Update Submitted That Met QC Criteria
June 4, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FT-Cv1.1
- R43AG058399 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Falls (Accidents) in Old Age
-
University of WashingtonNational Institute of Nursing Research (NINR)CompletedFalls (Accidents) in Old AgeUnited States
-
Joel BelminUnknownFalls (Accidents) in Old AgeFrance
-
Ain Shams UniversityRecruitingPsychotropic Drugs | Falls (Accidents) in Old AgeEgypt
-
University Hospital, MontpellierNot yet recruitingFall Prevention | Falls (Accidents) in Old AgeFrance
-
Youngstown State UniversityYMCANot yet recruitingFall | Fall Injury | Falls (Accidents) in Old AgeUnited States
-
University GhentRecruitingFalls (Accidents) in Old Age | Falls Risk | Community Dwelling Older Adults | Aged 65 Years or OlderBelgium
-
Kahramanmaras Sutcu Imam UniversityCompletedFalls (Accidents) in Old Age | Malnutrition Elderly | Depression in Adults | Post-Traumatic Stress Disorder in Old Age | Frailty at Older AdultsTurkey (Türkiye)
-
Rhode Island HospitalNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedFalls (Accidents) in Old AgeUnited States
-
Rune Skovgaard RasmussenNot yet recruitingHypogonadal Males | Falls (Accidents) in Old Age | Frail Elderly Patients | Testosterone Replacement TherapyDenmark
-
Samsung Medical CenterCompletedGait Disorders in Old AgeKorea, Republic of
Clinical Trials on FallsTalk-C
-
IlDong Pharmaceutical Co LtdCompleted
-
International Centre for Diarrhoeal Disease Research...University of California, DavisCompletedMalnourished Children
-
ANRS, Emerging Infectious DiseasesEuroVacc FoundationCompletedHIV InfectionsFrance, Switzerland
-
Eli Lilly and CompanyCompletedAdvanced CancerUnited Kingdom
-
Joshua M HareCompletedHypoplastic Left Heart SyndromeUnited States
-
Direction Centrale du Service de Santé des ArméesRecruitingEating Habit | Cold Exposure | HeatFrance
-
Kolon Life ScienceCompletedDegenerative ArthritisKorea, Republic of
-
Eli Lilly and CompanyCompleted
-
Alaunos TherapeuticsUnknownAdvanced Solid Tumors | LymphomasCanada
-
The University of Texas at DallasNational Institute on Aging (NIA); University of Texas Southwestern Medical...CompletedFunctional Magnetic Resonance Imaging | Cognitive AgingUnited States